Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
NCT ID: NCT07302295
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
6500 participants
INTERVENTIONAL
2025-12-31
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).
Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.
The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)
* Name : Group 1
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022.
* Age ≥ 8 years old and \< 18 years old between 2020 and 2022.
Aggregated data collection
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)
* Name : Group 1b
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents
* Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects.
* One or both parents
* Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects).
* Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.
Data collection and qualitative interview
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
Subjects control with suicidal behaviors before the health crisis (Group 2).
* Name: group 2
* Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region
* Age ≥ 8 years old and \< 18 years old between 2018 and 2019
Aggregated data collection
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aggregated data collection
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
Data collection and qualitative interview
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-adolescents (≥ 8 years and \< 11 years)
* Adolescents (≥ 11 years and \< 15 years)
* Older adolescents (≥ 15 years and \< 18 years)
Subjects with suicidal behavior during the health crisis (Group 1):
* Age \> 8 years and \< 18 years during the period 2020 to 2022.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
* Age \> 8 years and \< 18 years during the period 2020 to 2022.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
* Randomly selected from the population of Group 1.
* For whom the parent(s) and/or the subject have signed informed consent.
Controls with suicidal behavior before the health crisis (Group 2):
* Age \> 8 years and \< 18 years during the period 2018 to 2019.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
Exclusion Criteria
• Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.
Controls with Suicidal Behavior before the Health Crisis (Group 2):
* Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
* Intercurrent illness with a life expectancy of less than 24 hours.
For Group 1:
* Pregnant, postpartum, or breastfeeding women.
* Persons deprived of liberty by judicial or administrative decision.
* Adults subject to a legal protection measure (guardianship, curatorship).
* Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
* Persons who do not understand and do not speak French.
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent
Bron, , France
CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent
Clermont-Ferrand, , France
CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent
Grenoble, , France
CHU de Saint-Etienne - Urgences psychiatriques
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Elise MAMIMOUE, Dr
Role: primary
Jonathan Lachal, Pr
Role: primary
Stéphanie Bioulac, Dr
Role: primary
Catherine Massoubre, Pr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02237-38
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL22_1175
Identifier Type: -
Identifier Source: org_study_id